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ABSTRACT 
Garlic is one of the medicinal plants, which has shown many useful effects, including Antioxidant activity, hypolipidemic 
and hypocholesterolemic effects, anti-hypertensive and anti-diabetic effects. Scavenger receptor class B type I (SR-BI) is 
a cell-surface receptor which mediated selective cholesterol ester uptake from the HDL particle. SR-BI also has an 
important role in cholesterol absorption in the intestine.  Animals were randomly divided into three groups (n=8); group 1:  
received chow + cholesterol (2%) + cholic acid (0.5%), group 2: chow + 4% (w/w) garlic extract + cholesterol (2%) + cholic 
acid (0.5%), and group 3: chow only. After one-month mice were sacrificed, blood was collected; lipid profile and blood 
glucose were determined enzymatically as well as mRNA and protein levels of SR-BI were determined by RT-PCR and 
westernblot respectively. Compared with hypercholesterolemic control, garlic extract significantly decreased total 
cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides, Very Low-Density Lipoprotein-Cholesterol 
(VLDL-C) and  atherogenic index (all of them P<0.05). The activity of  Super oxide dismutase(SOD), glutathione (GSH) 
 and catalase levels were markedly increased in garlic-treated animals compared with hypercholesterolemic animals 
(p<0.05). The plasma levels of MDA markedly reduced in garlic group compared with hypercholesterolemic group. 
Intestinal SR-BI mRNA and protein were significantly decreased in garlic extract mice treatment compared with 
hypercholesterolemic control. Levels of liver SR-BI protein significantly reduced in hypercholesterolemic group (P<0.05). 
In conclusion, garlic extract markedly reduced TC, LDL-C, TG, VLDL-C and atherogenic index, as compared with the 
hypercholesterolemic control group. On the other hand garlic extract led to down-regulation of SR-BI protein and mRNA in 
the intestine of mice. 
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INTRODUCTION  
High levels of total cholesterol and low-density lipoprotein cholesterol (LDL-C) along with low serum levels of high-density 
lipoprotein cholesterol (HDL-C) is contributing    to the development of atherosclerosis [1]. In this respect, garlic extracted 
(Allium sativum) is a food component which usually used in our food. Furthermore, garlic extract have been shown to be 
applicable in atherosclerosis, because this herb has many useful properties, including; Antioxidant activity, anti-
hypertensive activity, hypolipidemic and hypocholesterolemic effects, anti-diabetic, anti-hyperhomocysteinemia and 
antithrombotic   effects [2]. Scavenger receptor class B member 1 (SR-BI) is a cell-surface receptor which mediated 
selective cholesterol ester uptake from the center of the HDL particle. In this process cholesterol, ester is transferred to the 
liver cell without degradation of this protein [3]. SR-BI is expressed with high levels in the liver and steroidogenic cells. 
Mutations in the SR-BI gene in mice who is inhibited or reduced SR-BI expression leads to rise in plasma HDL-C 
concentrations and decrease HDL-CE uptake by the liver [4].  On the other hand, transgenic mice expression of high 
levels of liver SR-BI leads to decrease in serum levels of high-density lipoprotein (HDL) cholesteryl ester (CE), 
Apolipoprotein AI (Apo AI), and Apolipoprotein AII (Apo AII) [5].   
The molecular mechanisms of cholesterol absorption in the intestine are yet not entirely understood. However, many 
proteins,  including scavenger  receptor  BI (SR-BI),  Niemann-Pick C1-like  1  (NPC1L1), aminopeptidase  N and ATP-
binding  cassette  transporter  G5/G8  (ABCG5/G8)  have  been  proposed  as candidates of cholesterol transporters or 
receptors [6].The present study was performed to investigate the effect of garlic extract on altered biochemical parameters 
and expression of SR-BI in liver and intestine of N-marry mice.   
EXPERIMENTAL PROCEDURE  
Male N-Mary mice weighing 28-30 g each were kept in animal cages, maintained on 12h light/12 h dark cycle cycles at 
room temperature of 22 ± 1°C. They were fed commercial store diet and water. Animals acclimatized for one week and 
then were randomly divided into three groups (n=8):  group 1 received chow + cholesterol (2%) + cholic acid (0.5%), group 
2: chow + 4%(w/w) garlic extract + cholesterol (2%) + cholic acid (0.5%), and group 3: chow only. Triglyceride, cholesterol 
and blood glucose, were at the baseline prior to treatment. Animals were supervised every day, and body weight was 
recorded every 48hrs. After one-month treatment, the mice were anesthetised with sodium thiopental and sacrified and 
then blood samples were collected from heart. After that, blood samples allowed to clot, and was centrifuged at 3000 g for 
10 minutes and then stored at -20°C until assay. Liver and intestine were removed, washed with Phosphate buffered 
saline (PBS) and stored in –70 
o
C until use. All experiments procedure of this study was approved by the Animal Research 
Ethic Committee of Kerman Medical University (Kerman, Iran). Fasting blood glucose, triglyceride, total cholesterol and 
HDL-C were measured enzymatically. The LDL-C and VLDL-C were calculated using Friedwald equation. Atherogenic 
index was calculated by using the following formula [7- 9]: 
 
Antioxidant enzyme assays and Lipid peroxidation 
The superoxide dismutase (SOD) activity (Misra and Fridovich method), Catalase (CAT) (Aebi method) was determined, 
Reduced glutathione (GSH) (Beutler E, method) and MDA levels (Ohkawa method) were determined [9]. 
Garlic extract 
The garlic cloves were purchased from market of medicinal herbal in Kerman city, and then were washed with distilled 
water, and dried. Twenty grams of shadow dried powder dissolved in 200 ml of distilled water at room temperature for 24 
h. the extract filtrated and after that was dried at 40°c in an incubator. The extract was kept in dark vials at -20°C [10].   
Reverse transcriptase PCR   
Total RNA from liver and intestine were extracted using Accuzol Reagent and also cDNA synthesis was performed 
according to the manufacturer’s instructions (Bioneer, Korea and Fermentas, Lithuania respectively). For reverse 
transcriptase PCR (RT-PCR) reaction, 35 cycles of PCR amplification were achieved with denaturation at 95  ºC for 30 s, 
annealing at 63 ºC for 30 s, and extension at 72 ºC for 30 s with using PCR machine. Finally, all PCR reactions were 
completed with a single extension cycle at 72 ºC for 5 minutes. The products were electrophoresed on a 2.5% agarose gel 
and visualized by staining with ethidium bromide. The following primers were used in this study. Mouse Beta actin Primer; 
forward (F):  5’-TGG AAT CCT GTG GCA TCC ATG AAA C-3’ and reverse (R): 5’-TAA AAC GCA GCT CAG TAA CAG 
TCC G-3’. Mouse SR-BI primer; forward (F): 5'-CAC CTT CAA TGA CAA CGA CAC C-3'and reverse (R): 5'-TCT CTG 
AGC CAT GCG ACT TG-3' [8]. 
Western blot analysis 
Fifty milligram of liver or intestine were homogenized in 700 µl of RIPA buffer containing 1µM PMSF and 1% protein 
inhibitor cocktail (Santa Cruz, USA), after that centrifuged (14000 rpm) at 4 ºC for 15 minutes. The extracted total proteins 
(60 µg), were separated onto a 12.5 % SDS-PAGE gel and were transferred onto a PVDF membrane (Roche Applied 
Science). The membrane was incubated with SR–BI (1:2500 dilution, Novus Biological)  for 1.5 h at room temperature 
after blocking with 2% skim milk in Tris-buffered saline containing Tween-20 (TBS-T) (Roche Applied Science) for 2hrs. 
The blots then were incubated with horseradish peroxidase-conjugated anti-rabbit IgG (1:10 000 dilution, Roche Applied 
Science) at room temperature for 1.5 h. ECL Western blot analysis system (Roche Applied Science) was used to detect 
bound antibodies. The same membranes were reprobed with anti-β-actin antibodie (1:2500 dilution, Novus Biological) to 
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verify the equal loading of proteins prepared from liver and intestine after different treatments. Density of bands was 
determined with Lab Work analyzing software (UVP, UK), and data are expressed as the percent ratio of the SR-BI to β – 
Actin [11,12]. 
Statistical analysis 
The differences between treatment groups were analyzed by ANOVA (Tukey).  All results are presented as mean ± S.E.M 
and differences with at P<0.05 were considered significant. 
Results  
Body weight and Biochemical analysis  
Table 1 shows body weight, FBS, TC, LDL-C, HDL-C, TG and VLDL-C, in mice fed a high-cholesterol diet, garlic extract 
and chow. Body weight show significant increase in hypercholesterolemic control compared with chow diet; while garlic 
non-significantly reduced body weight. Reduction of Fasting Blood Sugar (FBS) in garlic-treated animals was not 
significant compared with hypercholesterolemic group. Serum TC, LDL-C, TG, VLDL-C and atherogenic index significantly 
decreased in garlic extract in comparison with hypercholesterolemic mouse. Change in Serum HDL-C between garlic 
extract and hypercholestrolemic groups were not significant in comparison with chow. 
Antioxidant activity 
The activity of SOD was markedly increased in garlic group (p < 0.05) when compared with hypercholesterolemic group. 
The levels GSH and catalase were also markedly increased in garlic group (p < 0.05) compared with hypercholesterolemic 
animals. The plasma concentration of MDA significantly reduced in garlic group compared with hypercholesterolemic 
animals (p < 0.05) (table 2).  
Levels of SR-BI protein and mRNA 
Immunoblot analysis of the intestine and liver protein probed with anti SR-BI revealed bands with expected size of 82 KDa. 
Intestinal SR-BI protein significantly reduced in garlic extract (P<0.05). Liver SR-BI significantly reduced in response to the 
hypercholestrolemic diet (combination of 2% cholesterol and 0.5% cholate) (hypercholesterolemic group) (P<0.05), while 
the change of SR- BI in liver of garlic extract group was not significant (Figure 1). PCR products of SR-BI showed an 
expected band of 82 bp. Intestinal SR-BI mRNA significantly reduced in garlic extract (P<0.05). Liver SR-BI mRNA had 
not been a significant change between all groups (Figure 2).  
Table 1: Comparison of biochemical factors between different treatment groups 
Biochemical factors   Control (Hypercholesterolemic)   Garlic                        Chow             
Body weight (g)          37.5 ± 1.5
f
                          35.7 ± 0.8                    30.7 ± 0.7   
FBS (mg/dl)                160.1 ± 5.6                        152.7  ± 4.6                 138.1 ± 9.7           
TC(mg/dl)                   230.1 ± 4.5 
f
                      191.4 ± 5.4
a
                 129 ± 13.4           
TG (mg/dl)                 160.5 ± 7.5 
d
                      137.4 ± 4.5
a
                 133.5 ± 4.0           
VLDL-C (mg/dl)          32.1 ± 1.5
d
                         27.5 ± 0.9 
a
                  26.7 ± 0.8           
HDL-C (mg/dl)            90.3 ± 8.1                         106.2 ± 3.8                   87.4 ± 9.7          
LDL-C (mg/dl)             98.8 ± 7.8
f
                         57.6 ± 7.4
a
                   24.9 ± 5.5    
AI                                1.6 ± 0.08
f
             0.8  ± 0.02
b
           0.48  ± 0.01                        
 
FBS: Fasting blood sugar, TC: Total cholesterol, TG: Triglyceride, HDL-c: High-density lipoprotein cholesterol, LDL-c: 
Low-density lipoprotein cholesterol, VLDL-c: Very low-density lipoprotein cholesterol, AI: atherogenic index. 
a
p < 0.05 
considered as significant compared with Hypercholestrolemic. 
b
p < 0.01 compared with Hypercholestrolemic.  
c
p < 0.001 
compared with Hypercholesterolemic. 
d
p < 0.01 compared with chow.  
f
p < 0.001 compared with chow.   Data represent as 
mean ± SEM (n = 8). 
Table 2: Antioxidant enzyme activities in the plasma of animals 
                             SOD(units/ml)    MDA (nmol/l)    GSH (µmol/ ml)     Catalase(units/ml)     
Chow                               112.5 ± 6.0         2.3 ± 0.16      6.33 ± 0.66              63.3 ± 5.9 
garlic                                120.0 ± 6.1
a
       2.5 ± 0.18
a
     6.08 ± 0.45
 a                  
60.1 ± 5.1
a 
    
Hypercholesterolemic 
       
141.1 ± 7.3         3.9 ± 0.20      4.17 ± 0.30              45.3 ± 6.4 
        
         
        
          
Data are expressed as mean ± SEM. 
a
p < 0.05 compared to Control (Hypercholesterolemic). SOD: 
Super oxide dismutase, MDA: malondialdehyde, GSH; glutathione.    
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Fig 1-A 
 
 
 
Fig 1-B 
Fig 1: Westernblot of SR-BI protein in intestine and liver of animals which treated differently. Fig 1-A:  The  average  band  
density  ratio  of intestinal SR-BI proteins  in  three groups including (n=8); control (hypercholesterolemic),  garlic  and 
chow  received.  Data in the graph are represented as mean ± SEM. **P < 0.01 versus chow animals. Fig1-B: The  
average  band  density  ratio  of liver SR-BI proteins  in  three groups including (n=8); control (hypercholesterolemic),  
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garlic  and chow  received.  Data in the graph are represented as mean ± SEM. β -Actin was used as an internal control. 
The density of liverl SR-BI protein significantly reduced in the in the high cholesterol diet (control) group compared with the 
chow. *P < 0.05 versus chow animals. 
 
 
Fig 2-A 
 
 
 
 
Fig 2-B 
Figure 2: Reverse Transcription PCR of SR-BI protein in intestine and liver of animals which treated differently. Fig 2-A: 
The  average  band  density  ratio  of intestinal SR-BI mRNA  in  three groups including (n=8); control 
(hypercholesterolemic),  garlic  and chow  received.  Data in the graph are represented as mean ± SEM. The density of 
ISSN 2321-807X 
789 | P a g e                      D e c e m b e r  0 5 ,  2 0 1 3  
intestinal SR-BI mRNA significantly reduced in the in the garlic group compared with the chow. **P < 0.01 versus chow 
animals. Fig 2-B: The  average  band  density  ratio  of liver R-BI mRNA  in  three groups including (n=8); control 
(hypercholesterolemic),  garlic  and chow  received.  Data in the graph are represented as mean ± SEM. β -Actin was 
used as an internal control. The change of liver SR-BI mRNA was not significant in all treatment groups.  
Discussion  
Many experiments using rabbit and rat have shown that garlic consumption significantly decreased the content of total 
serum cholesterol, LDL, VLDL, and also increased   the level of HDL [2]. Effendy, Simmons, Campbell, et al. results show 
that treatment with aged garlic extract (AGE) in hypercholesterolemic  rabbits significantly reduced accumulation of 
cholesterol in vessel  wall  and also inhibited development of arteriosclerotic plaques in the arterial wall [2]. In humans and 
animals study allicin, and its derivative are known as the major active compound responsible for the hypocholesterolemic 
and hypolipidemic effects of garlic.   
In   our   experiment, fed with high   cholesterol   diets significantly    increased    serum triglycerides, total cholesterol, 
LDL-C and VLDL-C.      
Our result was agreement with Kamanna VS, et al [13]. experiment which showed that, the increased levels of LDL-C and 
cholesterol in animals which fed the hypercholestrolemic diet were partly reversed in mice receiving a supplement of garlic 
powder.  
In this study  supplementation of diet with 4%  of garlic extract caused  a  significant  reduction   in  the  serum  total 
cholesterol (16%),   triglycerides (14.4 %),  LDL-C (41 %),VLDL-C (15 %) and atherogenic index (50 %) in mice. Previous   
studies   have  shown  that  treatment with  garlic  inhibited   hepatic  fatty  acid  synthesis and  as a result     reduced   the 
accumulation of lipid  in  the  liver,   and  the  triglycerides    level   in  the  plasma [14]. In   the   present study there was 
non-significant reduction in blood glucose in garlic extrac. The prior    reports   [15,16] showed that garlic had not influence 
on the concentration of serum glucose.  
A diversity of internal antioxidants including superoxide dismutase, catalase, glutathione peroxidase and peroxidase are 
present in organisms which protect them from oxidative stress. Antioxidants play vital role in maintenance of wellbeing and 
regular cellular activity. They protect body cells by stabilizing and deactivating of free radicals [9]. Moreover, peroxidation 
of lipid is one of the early events happening during in vitro oxidation of LDL, and consequently atherosclerosis formation. 
In the vessel wall atherogenic lipids especially oxidized low-density lipoprotein (ox-LDL) are responsible for a wide range 
of cellular dysfunctions [9]. The high MDA levels are recognized as a positive sign of lipid peroxidation. There was a 
significant raise in SOD, GSH and catalase in garlic-treated group. The MDA levels markedly reduced in in garlic-treated 
group compared with hypercholesterolemic group. 
SR-BI is one of the lipid transporters which have important role in lipid metabolism. SR-BI is an 82 kDa membrane protein 
highly expressed in liver, intestine and steroidogenic tissues. In the liver, SR-BI is the chief receptor which mediates 
selective uptake of cholesterol ester from plasma HDL [17].   
The results of our study have showed that liver SR-BI protein significantly down-regulated in an atherogenic diet 
(cholesterol 2% and cholic acid 0.5%). This finding is similar to Niemeier A, et al. [18] and Hong S, et al. [19] results that 
showed an atherogenic diet significantly reduced posttranslational expression of hepatocyte SR-BI protein levels. This 
reduction is maybe atherogenic diet leads to rise of liver cholesterol. We observed a non-significant reduction in HDL-C 
levels in hypercholesterolemic mice. In this study change of SR-BI protein and mRNA in garlic extract group was not 
significant.   
Absorption of lipid in intestine is an important contributor to the general balance of lipid metabolism. Diverse proteins have 
consecutively been concerned in intestinal lipid absorption. For example, CD-36 a multiligand scavenger receptor has 
projected to take up fatty acids and monoglycerides, however, could also contribute in cholesterol absorption. The other 
transporter is a Niemann-Pick C1 Like 1 (NPC1L1), which has an important role in cholesterol absorption. Intestinal 
cholesterol absorption in NPC1L1 knock-out mice decreased by 80%. In addition, aminopeptidase-N has been implicated 
in cholesterol absorption [3].  SR-BI is a main intestinal transport protein which inhibited by a potent cholesterol absorption 
inhibitor, SCH354909, derivative of ezetimibe [20]. SR-BI is expressed in membranes of enterocyte brush border, mostly 
at the apex side of intestinal villosities and also in the proximal piece of the intestine where cholesterol is mainly absorbed 
[3]. 
The gastrointestinal tract is known as a main potential therapeutic target in dyslipidemia management.  Restriction of 
dietary cholesterol and triglyceride has been utilized as the primary therapy in the whole-body cholesterol regulation [21]. 
SR-BI is one of the important intestinal cholesterol absorption transporters. In this experiment, SR-BI was significantly 
reduced in an intestine by garlic extract in comparison with control. Hauser H et al. reported that SR-BI played major role 
in absorption of cholesterol [22]. The ability of ezetimibe to inhibit of SR-BI proposed that this protein has an important role 
in cholesterol absorption. Altmann SW et al. also reported that SR-BI inhibited by SCH354909 (derived from ezetimibe) 
and has a vital role in intestinal cholesterol absorption (20). 
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Conclusion 
Interestingly, our results suggested that the garlic extract significantly decreased the TC, LDL-C, TG, VLDL-C and 
atherogenic index, as compared with the control group. Taken together,  we  confirmed  that  garlic  extract  dramatically 
suppress  the  atherosclerosis  risk  by improve antioxidant activity and also by reducing  total cholesterol  and triglyceride 
absorption via inhibition of intestinal SR-BI. Thus,  we  conclude  that  the  garlic  extract  have beneficial  effects  in  
lowering  the  incidence  of  cardiovascular disease (CVD) and  atherosclerosis  by  reducing  the  cholesterol and 
triglyceride absorption.  
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